Summary
The classical prion diseases in man comprise Creutzfeldt-Jakob disease (CJD), Kuru and Gerstmann-Sträussler-Scheinker syndrome (GSS). Recent advances in the biochemistry and the molecular biology of the transmissible agents responsible for these human spongiform encephalopathies have prompted renewed interest in their clinical and pathological features. A broadening spectrum of human prion diseases has now been identified including novel entities such as Fatal Familial Insomnia and variants of CJD and GSS characterised by specific abnormalities in the human prion protein (PrP) gene on chromosome 20. Accumulation of PrP in the central nervous system is a characteristic feature of all these disorders, although the relationship between PrP localisation, classical neuropathology, clinical features and genotype still requires clarification. A national surveillance project for CJD was established in 1990 in the United Kingdom in order to assess the possible implications of bovine spongiform encephalopathy for human health. The identification of an apparently new variant of CJD in young patients in UK raises the possibility of such a link; further studies are required to assess the significance of this observation.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Advisory Committee on Dangerous Pathogens (1994) Precautions for work with human and animal tranmissible spongiform encephalopathies, 1st edn. HMSO, London
Amouyel P, Vidal O, Launay JM, Laplanche JL (1994) The apolipoprotein E alleles as major susceptibility factors for Creutzfeldt-Jakob disease. Lancet 344: 1315–1318
Anonymous (1990) Prion disease - spongiform encephalopathies unveiled. Lancet 336: 21–22
Askanas V, King EW, Alverez RB (1992) Light and electron microscopic localisation of (3-amyloid protein in muscle biopsies of patients with inclusion-body myositis. Am J Pathol 141: 31–36
Askanas V, Bilak M, Engel WK, Alvarez RB, Tome F, Leclerc A (1993) Prion protein is abnormally accumulated in inclusion-body myositis. Neuro Report 5: 25–28
Baker HF, Ridley RM (1992) The genetics and transmissibility of human spongiform encephalopathy. Neurodegen 1: 3–16
Bastian FO (ed) (1991) Creutzfeldt-Jakob disease and other transmissible human spongiform encephalopathies. Mosby Year Book, St Louis
Bell JE, Ironside JW (1993a) Neuropathology of spongiform encephalopathies in humans. Br Med Bull 49: 738–777
Bell JE, Ironside JW (1993b) How to tackle a possible Creutzfeldt-Jakob disease necropsy. J Clin Pathol 46: 193–197
Bradley R, Wilesmith JW (1993) Epidemiology and control of bovine spongiform encephalopathy (BSE). Br Med Bull 49: 932–959
Brown P, Wolff A, Gajdusek DC (1990) A simple and effective method for inactivating virus infectivity in formalin-fixed tissue samples from patients with Creutzfeldt-Jakob disease. Neurology 40: 887–90
Brown P, Preece MA, Will RG (1992) “Friendly fire” in medicine: hormones homografts and Creutzfeldt-Jakob disease. Lancet 340: 24–27
Brown P, Crevenakova L, Boellaard JW, Stavrou D, Goldfarb LG, Gajdusek DC (1994) Identification of a PRNP gene mutation in Jakob’s original Creutzfeldt-Jakob disease family. Lancet 344: 130–131
Budka H, Aguzzi A, Brown P, Brucher J-M, Bugiani O, Gullotta F, Haltia M, Hauw J-J, Ironside JW, Jellinger K, Kretzschmar HA, Lantos PL, Masullo C, Scholte W, Tateishi J, Weller RO (1995) Neuropathological diagnostic criteria for CreutzfeldtJakob disease (CJD) and other human spongiform encephalopathies (prion diseases). Brain Pathol 5: 459–465
Bugiani O, Giaccone G, Verga L, Pollo B, Frangione B, Farlow MR, Tagliavini F, Ghetti B (1993) (3PP participates in PrP-amyloid plaques of Gerstmann-Sträussler-Scheinker disease, Indiana kindred. J Neuropathol Exp Neurol 52: 66–70
Collinge J, Owen F, Poulter M, Leach M, Crow TJ, Rossor MN, Mullan MJ, Janota I, Lantos PL (1990) Prion dementia without characteristic pathology. Lancet 336: 7–9
Collinge J, Palmer MS, Dryden AJ (1991) Genetic predisposition to iatrogenic Creutzfeldt-Jakob disease. Lancet 337: 1441–42
Collinge J, Palmer MS, Sidle KCL, Gowland I, Medori R, Ironside JW, Lantos P (1995) Tranmission of fatal familial insomnia to laboratory animals. Lancet 346: 569–570
Creutzfeldt HG (1920) Über eine eigenartige herdförmige Erkrankung des Zentralnervensystems. Z Ges Neurol Psychiat 57: 1–18
De Silva R, Ironside JW, McCardle L, Esmonde T, Bell JE, Will RG, Windle O, Dempster M, Estibeiro P, Lathe R (1994) Neuropathological phenotype and “prion protein” genotype correlation in sporadic Creutzfeldt-Jakob disease. Neurosci Lett 179: 50–52
DeArmond SJ (1993) Alzheimer’s disease and Creutzfeldt-Jakob disease: overlap of pathogenic mechanisms. Curr Opin Neurol 6: 872–881
Delasnerie-Laupretre N, Poser S, Pocchiari M, Wientjens DPW, Will R (1995) Creutzfeldt-Jakob disease in Europe. Lancet 346: 898
Frasier SD, Foley Jr TP (1994) Creutzfeldt-Jakob disease in recipients of pituitary hormones. J Clin Endocrinol Metabol 78: 1277–1279
Gajdusek DC, Zigas V (1957) Degenerative disease of the central nervous system in New Guinea. The endemic occurrence of “kuru” in the native population. N Engl J Med 257: 974–978
Gajdusek DC, Gibbs CJ, Alpers MP (1966) Experimental transmission of a kuru-like syndrome in chimpanzees. Nature 209: 794–796
Gambetti P, Peterson R, Monari L, Tabaton M, Autillo-Gambetti L, Cortelli P, Montagna P, Lugaresi E (1993) Fatal familial insomnia and the widening spectrum of prion diseases. Br Med Bull 49: 980–994
Gerstmann J, Sträussler E, Scheinker I (1936) Über eine eigenartige hereditär-familiäre Erkrankung des Zentralnervensystems, zugleich ein Beitrag zur Frage des vorzeitigen lokalen Alterns. Z Neurol Psych 154: 736–762
Gibbs CJ, Gajdusek DC, Asher DM, Alpers MP, Beck E, Daniel PM, Matthews WB (1968) Creutzfeldt-Jakob disease (subacute spongiform encephalopathy): transmission to the chimpanzee. Science 161: 388–389
Goldfarb LG, Brown P, Cervenakova L, Gajdusek CJ (1994) Molecular genetic studies of Creutzfeldt-Jakob disease. Mol Neurobiol 8: 89–97
Goodbrand IA, Ironside JW, Nicolson D, Bell JE (1995) Prion protein accumulation in the spinal cords of patients with sporadic and growth hormone associated Cruetzfeldt-Jakob disease. Neurosci Lett 183: 127–130
Hainfellner JA, Brantner-Inthaler S, Cercenakova L, Brown P, Kitamoto T, Tateishi J, Diringer H, Liberski PP, Regele H, Feucht M, Mayr N, Wessely P, Summer K, Seitelberger F, Budka H (1995) The original Gerstmann-Sträussler-Scheinker family of Austria: divergent clinicopathological phenotypes but constant PrP genotype. Brain Pathol 5: 201–213
Hansen LA, Masliah E, Terry RD, Mirra SS (1989) A neuropathological subset of Alzheimer’s disease with concomitant Lewy body disease and spongiform change. Acta Neuropathol 78: 194–201
Hayward PAR, Bell JE, Ironside JW (1994) Prion protein immunocytochemistry: the development of reliable protocols for the investigation of Creutzfeldt-Jakob disease. Neuropathol Appl Neurobiol 20: 375–383
Hsiao KK, Doh-ura K, Kitamoto T, Tateishi J, Prusiner SB (1989) A prion protein amino acid substitution in ataxic Gerstmann-Sträussler syndrome. Ann Neurol 26: 137
Jakob A (1921) Über eigenartige Erkrankungen des Zentralnervensystems mit bemerkenswertem anatomischen Befunden (Spastische PseudoskleroseEncephalomyelopathie mit disseminierten Degenerationsherden). Z Ges Neurol Psychiat 64: 147–228
Jendroska K, Hoffmann O, Schelosky L, Lees AJ, Poewe W, Daniel SE (1994) Absence of disease related prion protein in neurodegenerative disorders presenting with Parkinson’s syndrome. J Neurol Neurosurg Psychiatry 57: 1249–1251
Kitamoto T, Shin RW, Doh-ura K, Tomokane N, Miyazono M, Muramoto T, Tateishi J (1992) Abnormal isoform of prion protein accumulates in the synaptic structures of the central nervous system in patients with Creutzfeldt-Jakob Disease. Am J Pathol 140: 1285–129
Klatzo I, Gajdusek DC, Vigas V (1959) Pathology of kuru. Lab Invest 8: 799–847 Lugaresi E, Medori R, Montagna P, Baruzzi A, Cortelli P, Lugaresi A, Tinuper P, Zucconi M, Gambett P (1986) Fatal familial insomnia and dysautonomia with selective degeneration of thalamic nuclei. N Engl J Med 315: 997–1003
Martinez-Lage JF, Poza M, Sola J, Tortosa JG, Brown P, Crevenakova L, Esteban JA, Mendoza A (1994) Accidental transmission of Creutzfeldt-Jakob disease by dural cadaveric grafts. J Neurol Neurosurg Psychiatry 57: 1091–1904
Masters CL, Richardson EP (1978) Subacute spongiform encephalopathy (CreutzfeldtJakob disease). The nature and progression of spongiform change. Brain 101: 333–334
Masters CL, Gajdusek DC, Gibbs CJ (1981) Creutzfeldt-Jakob disease: virus isolates from the Gerstmann-Sträussler syndrome. Brain 104: 559–588
Medori R, Tritschler JH, LeBlanc A, Villare F, Manetto V, Ghen HY, Xuf R, Leal S, Montagna P, Cortelli P, Tinuper P, Avoni P, Mochi M, Baruzzi A, Hauw JJ, Ott J, Lugarest E, Autilio-Gambettia L, Gambetti P (1992) Fatal familial insomnia, a prion disease with a mutation at codon 178 of the prion protein gene. N Engl J Med 7: 444–449
Metters JS (1990) Neuro and ophthalmic surgery procedures in patients with or suspected to have or at risk of developing CJD or GSS. Letter PL(92)CO/4 to Consultants and Health Managers, Department of Health, London
Neumann MA, Gajdusek DC, Vigas V (1965) Neuropathologie findings in exotic neurologic disorders among natives of the highlands of New Guinea. J Neuropathol Exp Neurol 18: 486–507
Nieto A, Goldfarb LG, Brown P, McCombie WR, Trapp S, Asher DM, Gajdusek DC (1991) Codon 178 mutation in ethnically diverse Creutzfeldt-Jakob disease families. Lancet 337: 622–623
Petersen RB, Tabaton M, Chen SG, Monari L, Richardson SL, Lynches T, Manetto V, Lanska DJ, Markesbery WR, Currier RD, Autilio-Gambetti L, Wilhelmsen KC, Gambetti P (1995) Familial progessive subcortical gliosis: presence of prions and linkage to chromosome 17. Neurology 45: 1062–1067
Pickering-Brown SM, Mann DMA, Owen F, Ironside JW, de Silva R, Roberts DA, Balderson DJ, Cooper PN (1995) Allelic variations in apolipoprotein E and prion protein genotype related to plaque formation and age of onset in sporadic Creutzfeldt-Jakob disease. Neurosci Lett 187: 127–129
Prusiner S B (1994) Biology and genetics of prion disease. Ann Rev Microbiol 48: 655–686
Richardson EP Jn, Masters CL (1995) The nosology of Creutzfeldt-Jakob disease and conditions related to the accumulation of PrPcm in the nervous system. Brain Pathol 5: 33–41
Smith PEM, Zeidler M, Ironside JW, Estibeiro P, Moss TH (1995) Creutzfeldt-Jakob disease in a dairy farmer. Lancet 346: 898
Wells GAH, Scott AC, Johnson CT, Gunning RF, Hancock RD, Jeffrey M, Dawson M, Bradley R (1987) A novel progressive spongiform encephalopathy in cattle. Vet Rec 121: 419–420
Westaway D, DeArmond SJ, Cayetano-Canlas J, Groth D, Foster D, Yang S, Torchia M, Carlson GA, Prusiner SB (1994) Degeneration of skeletal muscle, peripheral nerves and the central nervous system in transgenic mice overexpressing wild-type prion proteins. Cell 76: 117–129
Will RG (1991) The spongiform encephalopathies. J Neurol Neurosurg Psychiatry 54: 761–763
Will RG (1993) Epidemiology of Creutzfeldt-Jakob disease. Br Med Bull 49: 960–970
Will RG, Ironside JW, Zeidler M, Estibeiro K, Alperovitch A, Poser S, Pocchiari M, Hofman A, Smith PG (1996) A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 347: 921–925
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer-Verlag
About this paper
Cite this paper
Ironside, J.W. (1996). Human prion diseases. In: Jellinger, K.A., Windisch, M. (eds) New Trends in the Diagnosis and Therapy of Non-Alzheimer’s Dementia. Journal of Neural Transmission Supplement, vol 47. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6892-9_16
Download citation
DOI: https://doi.org/10.1007/978-3-7091-6892-9_16
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-82823-6
Online ISBN: 978-3-7091-6892-9
eBook Packages: Springer Book Archive